COOKIES USE
We use necessary system cookies for the correct functioning of the website and optional Google Analytics cookies to obtain visit statistics.
 +info

Cookies config

  • Necessary

    The necessary cookies are absolutely essential for the website to work properly. This category only includes cookies that guarantee basic website security and functionality. These cookies do not store any personal information.

    NameProveedorPropiedadFinalidadCaducidad+info
    _GRECAPTCHAgoogle.comOwnprovide antispam protection with the reCaptcha service6 months
    cc_cookie_acceptfidmag.orgOwnUsada per confirmar que l'usuari ha confirmat / refusat les cookies (i quins tipus accepta)1 any
    WEB_SESSIONfidmag.orgOwnCookie técnica: cookie de sessió PHP. Guarda l'id de sessió d'usuari.al acabar la sessió

  • Analisys

    Analytical cookies are used to understand how visitors interact with the website. These cookies help to provide information on meters, the name of visitors, the percentage of bounces, the font of the traffic, etc.

    NameProveedorPropiedadFinalidadCaducidad+info
    _gaGoogle AnalyticsFrom third partiesCookie d'anàlisi o mesurament: Identifica els usuaris i proporciona informació sobre com els usuaris troben la pàgina web i com la utilitzen per a realització d'Informes estadístics2 anys
    _gat_gtag_UA_141706552_1Google AnalyticsFrom third partiesCookie d'anàlisi o mesurament: Tracking per part de google per google analytics1 minut
    _gidGoogle AnalyticsFrom third partiesCookie d'anàlisi o mesurament: S'usa per limitar el percentatge de sol·licituds24 hores

ConfigureReject allAccept

Title

Neurodevelopment markers and schizophrenia: analysis of their shared genetic underpinnings and the modulation effect of prenatal stress

Summary

Based on evidence about the heritability of schizophrenia (SZ), the genetic determinants of dermatoglyphic patterns and the role of dermatoglyphics as risk markers of SZ, we propose an innovative approach, in which biology, genomics and psychiatry converge to go one step further from basic research to clinical applicability. Combining phenomics of the dermatoglyphics pattern with genomics, we aim to: i) improve our understanding of the neurodevelopment pathological processes associated with SZ, ii) to identify non-invasive biomarkers that can be translated into the clinical practice to improve the diagnosis characterisation and prognosis of SZ.

We will investigate: i) the common genetic underpinnings of SZ liability and dermatoglyphic patterns, by analysing the association of hand dermatoglyphics with the Polygenic Risk Score (PRS) for SZ; ii) whether the relationship between the PRS for SZ and the dermatoglyphic patterns is also detectable in other neurodevelopment disorders such as Autism Spectrum Disorders (ASD); iii) the influence of such genetic underpinnings on the sensitivity to prenatal stress.

The design we propose to develop these aims includes different sample types, each representing different genetic/ environmental load for the disorder and/or for neurodevelopment disturbances. Case-control sample: 617 individuals with a diagnostic of SZ and 400 healthy controls. Family-based samples: 80 trios with an offspring with a diagnostic of SZ, 80 trios with an offspring with ASD, 40 mother-child dyads (women with a diagnostic within the psychosis-spectrum).

 

Amount

62.315,00 €

 

Financing entity

Instituto de Salud Carlos III, with co-financing from the European Regional Development Fund "A way of making Europe".

 

 

Logo MICINN Banner ISCIII Logo UE 2022
We are part of
HH Província España
Contact us

Avda. Jordà, 8, 08035 Barcelona
Contact phone: 935 480 105
E-mail: fundacio@fidmag.org
Online contact 

           

 

Reconocimientos a la calidad y la excelencia
Última modificación: 22/11/2024